Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (601-610 of 1,058) with videos related to

Pageof 106
Sort By:
British Journal of Haematology|July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaSamantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Therapeutic Drug Monitoring|August 19, 2008
Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasmaQing Liu, Katherine L Farley, Amy J Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Cancer Medicine|March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemiaDaphne Guinn, Amy Lehman, Catherine Fabian, et al.
Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.
Blood|May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemiaTimothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cellsSneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
Molecular Biosystems|September 24, 2013
Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysisSompop Bencharit, Sarah Schwartz Baxter, Jim Carlson, et al.
Pageof 106

Showing results (601-610 of 1,058) with videos related to

Sort By:
Pageof 106
British Journal of Haematology|July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaSamantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.
Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Therapeutic Drug Monitoring|August 19, 2008
Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasmaQing Liu, Katherine L Farley, Amy J Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2022
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for InterventionAndrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Cancer Medicine|March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemiaDaphne Guinn, Amy Lehman, Catherine Fabian, et al.
Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.
Blood|May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemiaTimothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cellsSneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
Molecular Biosystems|September 24, 2013
Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysisSompop Bencharit, Sarah Schwartz Baxter, Jim Carlson, et al.
Pageof 106